Introduction
Amyloid-beta precursor protein (APP) was discovered 25 years ago by four groups (Goldgaber et al., 1987; Kang et al., 1987; Robakis et al., 1987; Tanzi et al., 1987) , but its cellular roles remain uncertain. Its enigmatic function is typified by the fact that it is a large, 770 amino acid, transmembrane protein, and yet its name derives from the 37-43 amino acid proteolytic fragments that form amyloid-beta (Ab) plaques in Alzheimer's Disease (AD). The mammalian APP family comprises three genes that encode APP and two other APPlike proteins, APLP1 and APLP2. All three proteins are type I transmembrane proteins with similar structure and membrane topology; however, Ab peptides can be generated only from APP. Each of the APP/APLPs can mediate cell-cell adhesion and signaling (Soba et al., 2005; reviewed in Baumkö tter et al., 2012) . Diminishment or failure of synaptic transmission produces loss of cognitive ability in AD. Intriguingly, recent Cleavage by b-secretase produces a large soluble domain denoted APPsb (green box) and a carboxy-terminal fragment (bCTF). Cleavage by a-secretase produces a large soluble domain denoted APPsa (green box with red box). APPsa is identical to APPsb except for an additional sixteen amino acids (red box). Another carboxy-terminal fragment is also created (aCTF) that differs from bCTF in that it is missing the sixteen amino acids segment. The carboxy-terminal fragments are cleaved by c-secretase, a complex of four proteins that carries out regulated intramembrane proteolysis (RIP). Cleavage of CTFs produces Ab peptide (forms Ab plaques) or p3 (a 3 kDa peptide of unknown function) and AICD (APP intracellular domain) which may regulate transcription. APPsb is further cleaved by an unknown protease to produce a 35 kDa fragment of the N-terminal 286 amino acids (N-APP), which initiates neurodegenerative and axonal pruning during embryonic development. (B) A stop codon at the proteolytic site for a-secretase was inserted into the endogenous APP gene. Homozygous animals generate only APPsa under the control of the endogenous promoter. Domains are not to scale; for example APPsb (green box) is actually about 40 times larger than the separation between a-and b-secretase sites (red box).
studies using in vivo model systems have shown that all three members of the APP/APLP family are important for formation, maintenance, and plasticity of synapses in the CNS and PNS Ring et al., 2007; Taylor et al., 2008; Lee et al., 2010; Weyer et al., 2011 ; for reviews, see Aydin et al., 2012; Mü ller and Zheng, 2012) . This lends support to early suggestions that cognitive impairments in AD may stem not only from Ab peptides but also from disruption of the physiological functions of the APP/APLP holoproteins or proteolytic fragments.
Alternative splicing of mammalian APP transcripts generates three major isoforms: APP 695 (the predominant splice variant in the brain), APP 751 , and APP 770 . All of these variants have a large extracellular region with multiple binding domains, a short transmembrane domain, and a small cytoplasmic region with binding motifs for a multitude of adapter proteins involved in signaling. Proteolytic processing by proteases, called a-, b-, and c-secretases, generates a variety of proteolytic fragments, one of which is the Ab peptide (Fig. 1A) . The holoproteins and many of the proteolytic products have physiological functions (see reviews by Brunholz et al., 2012 and Haass et al., 2012 for APP processing and intracellular trafficking). a-and b-secretases cut APP in the juxtamembrane region of the extracellular domain and create APPsa and APPsb, respectively (Fig. 1A) , which are large soluble ectodomains of about 600 amino acids. Consequently, APPsa and APPsb are identical in the $600 N-terminal amino acids and differ only in the extra sixteen amino acids of APPsa (Fig. 1, red box) . The 16 amino acids apparently confer a ''neuroprotective'' function on APPsa (described in more detail for APP transgenic mice in Section 3.2). Following either a-or bcleavage, c-secretase cuts the remaining membrane bound fragment (called CTFa and CTFb, see Fig. 1A , bottom row of products) within the membrane to generate APP intracellular domain (AICD) and either Ab (amyloidogenic) or p3 (nonamyloidogenic). AICD is released into the cytoplasm from the membrane and although it has been proposed to be a transcriptional regulator, there is evidence both for and against this role (Cao and Sü dhof, 2001; Hé bert et al., 2006; Giliberto et al., 2008; Mü ller et al., 2008; Aydin et al., 2011) . An N-terminal fragment of APP (N-APP 286 ) derived from APPsb was identified as a ligand for death receptor 6 (DR6), a member of the TNFR gene family (Nikolaev et al., 2009) . During the period of growth factor dependent axonal outgrowth (E14-17, but apparently not later), N-APP induces axon retraction (pruning) of peripheral sensory neurons followed by apoptosis. The in vivo significance of the APP-DR6 interaction in the adult organism is unclear because in brain and transfected cells APPsb appears stable (Li et al., 2010; Guo et al., 2012) .
APP and APLP2 are expressed ubiquitously throughout the body with especially abundant expression in the nervous system; whereas APLP1 is reported to be predominantly expressed in the nervous system (Tanzi et al., 1987; Wasco et al., 1992; Lorent et al., 1995) . In situ hybridization to determine RNA levels of APP family members in sections of mouse brain shows extensive overlap of expression of all three homologues with widespread distribution in the brain (see brain atlas of the Allen Brain Institute, http://mouse.brain-map.org/). APP/APLP research has largely focused on the central nervous system because APP is the source of Ab plaques that are hallmarks of AD. On the other hand, the peripheral nervous system provides many advantages for studying synaptic transmission. This is especially true for the NMJ, where many molecular interactions for CNS and PNS synapse formation have been discovered and characterized. APP/APLP expression in most systems of the PNS is incompletely understood; this includes motor and sensory neurons/axons, autonomic and enteric ganglia, and associated glial cells. Early studies, using antibodies for immunolabeling, produced inconsistent results in dorsal root ganglia, autonomic and enteric neurons (Arai et al., 1991; Calzada et al., 1994; Naves et al., 1994; Cabal et al., 1995) . It is significant that early immunolocalization studies were unable to test the specificity of the antibodies with knockout mice. A recent study used APP-KO mice to test the specificity of nine anti-APP antibodies that have been used for publications; the unsettling finding was that only one of these antibodies was specific when used for immunocytochemistry (Guo et al., 2012) . Moreover, Guo et al. (2012) reported that the APP-specific antibody labeled neurons but not glia in the brain. This lack of antibody specificity indicates that unless antibodies were carefully characterized, early reports of APP localization in both the PNS and CNS should be taken with extreme caution. These issues will be resolved with antibodies specific to defined domains and controls using mice with individual genes knocked out. There is better, although still incomplete, understanding of APP/APLP expression at the NMJ. APP is expressed in motor and sensory axons (Nikolaev et al., 2009) and is targeted to presynaptic terminals (Sisodia et al., 1993; Lyckman et al., 1998; Szodorai et al., 2009) . At the NMJ, APP was reported to be concentrated in muscle at the postsynaptic membrane (Askanas et al., 1992; Akaaboune et al., 2000; Schubert et al., 1991) . The location of APP in Schwann cells and kranocytes (see below) at the NMJ has not been investigated.
2.
In vivo expression in worm, fly, and fish model systems
The strong conservation of APP-related genes in different organisms is one reason that invertebrate models (Link, 2005) as well as nonmammalian vertebrate models have been attractive for investigating basic cellular actions of APP (Table 1). There is one cautionary note to consider when extrapolating properties of invertebrate APP-like proteins to mammals. Despite many conserved regions, evolutionary trees indicate that worm and fly APP genes separated on their own lineages from a primordial ancestor. Thus, the fly and worm APP-like genes are paralogues of APP and may be as functionally distinct from APP as APP is from APLP1 and APLP2 (Coulson et al., 2000) .
Nematode
Caenorhabditis elegans has a single APP paralogue, APL-1. Loss of APL-1 causes developmental arrest and death at the first larval stage, probably due to the inability to molt (Hornsten et al., 2007; Wiese et al., 2010) . The finding that the extracellular domain of APL-1 was sufficient to rescue viability (Hornsten et al., 2007 ) is intriguing because this domain in mice is sufficient to rescue viability of the APP/APLP2 double Wiese et al., (2010) . c Luo et al., (1992) . d Torroja et al., (1999) . e Ashley et al., (2005) . f Wentzell et al. (2012) . g Song and Pimplikar, (2012) . h Liao et al., (2012) . Li et al., 1996. j Wang et al., 2007. k Li et al., 2010. knockout (see below). Interestingly, Hornsten et al. (2007) also found that overexpression of APL-1 also produced defects (decreased movement and viability). A pharmacological approach was used to test neurotransmission in APL-1 knockdown or null animals. Application of aldicarb, an acetylcholinesterase inhibitor, leads to paralysis in control worms due to constant stimulation of postsynaptic receptors. Worms with reduced or missing APL-1 were hypersensitive to aldicarb (Wiese et al., 2010) . Neurotransmission was clearly defective but it is not known whether both central and peripheral synapses were affected. There are many genetic and technical advantages to using C. elegans, but the worm NMJ is more complex than the vertebrate NMJ. One complication is that muscles in the worm are modulated by GABAergic and cholinergic transmission (Richmond and Jorgensen, 1999) as well as transmitters released from dense core vesicles (Hammarlund et al., 2008) . Thus, it is not clear how to interpret these studies with respect to synaptic transmission at the NMJ.
Fruit fly
Drosophila, like C. elegans, has only one APP paralogue, APPL (Luo et al., 1990 ; reviewed by Poeck et al., 2012) . Unlike APP in mammals, APPL seems to be restricted to the fly nervous system. Processing by orthologs of a-, b-, and c-secretases is rather similar to that found in mammals with differences in some details. For example, the positions of cleavage by a-and b-secretases are reversed, with APPLa being smaller than APPLb. Remarkably, the neuroprotective effects are maintained for the a-secretase product despite the reversed site of cleavage and smaller size. Wentzell et al. (2012) showed that APPLa suppressed the loss of neurons in mutant Drosophila with progressive degeneration. Moreover, their comparison of the expression of a versus b secretases implied that secreted APPLa was protective while APPLb was deleterious. In contrast to the highly penetrant lethality observed in C. elegans, deletion of APPL produced a mild phenotype consisting of behavioral abnormalities (e.g., loss of fast phototaxis) and defects in synapse formation. Again, it is notable that expression of the secreted ectodomain was capable of rescuing the deficits. Recently, more detailed studies examining the survival of appl d null mutants over prolonged time revealed that lack of APPL considerably survival rate at any given age (Wentzell et al., 2012) . By means of gain-and loss-of-functions studies, crosstalk has been established between the APP family and Notch in the development of the peripheral nervous system (PNS) that affected the development of the mechanosensory organs (MSO). Mechanistically, this involved intracellular signaling via Numb and Dab1. Interestingly, both a null mutation (appl d ) and knockdown of APPL resulted in loss of MSOs (Merdes et al., 2004 ). An interaction between APP and Notch-signaling has also been reported in mammals. Numb, a cytosolic negative regulator of Notch, binds APP at the YENPTY site on AICD (Roncarati et al., 2002) . Moreover, full length Notch and APP bind to each other at their transmembrane domains or in regions close to the membrane (Oh et al., 2005) . Thus, APP may regulate Notch determination of cell fate and survival during development.
Loss of APPL results in a decrease in the number of synaptic boutons at the larval NMJ, and APPL overexpression causes an increase in the number of satellite boutons (Luo et al., 1992; Torroja et al., 1999) . This induction of presynaptic boutons has also been found for cholinergic, glutamatergic, and GABAergic terminals in the cortex of mice overexpressing the a-secretase ADAM10, which presumably increased levels of APPsa and decreased levels of APPsb (Bell et al., 2008) . Synaptic growth activity at Drosophila NMJ involves a complex between APPL, the cell adhesion molecule fasciclin II, and Drosophila Mint/X11 (Ashley et al., 2005) . Loss of APPL produces both pre-and postsynaptic changes at the NMJ. Miniature excitatory junction potential frequency (a presynaptic indicator of free Ca 2+ levels) and amplitude (an indicator of postsynaptic receptor density) were increased, but responses evoked by nerve stimulation were depressed, consistent with fewer boutons (Ashley et al., 2005) . Thus, APPL is a regulator of both pre-and postsynaptic development at the larval NMJ.
Zebrafish
Danio rerio are advantageous for the study of vertebrate embryonic development. Embryos develop outside the body, can be visualized due to their transparency, and can be manipulated with injections of antisense morpholino to suppress protein expression. Zebrafish have two orthologs of APP, designated APPa and APPb, which have both overlapping and unique distributions of expression at one day post fertilization (Musa et al., 2001 ). In addition, zebrafish have one ortholog each of the APP-like genes, Aplp and Aplp2. Knockdown of APPb led to stunted axonal growth and reduced branching of motor neurons in the brainstem and spinal cord. In the same study, knockdown of APPa did not affect axonal outgrowth but did impair neuronal migration (Song and Pimplikar, 2012) . Transposon gene trap integration experiments have created fish that express the ectodomains of APPa or Aplp2 fused to a fluorescent reporter protein. Both lines of fish are phenotypically normal, implying that the secreted ectodomains may fulfill many of the functions of the whole protein. Moreover, the secreted proteins accumulated in embryonic veins, consistent with a suggested role in angiogenesis (Liao et al., 2012) . Further studies with single and multiple KOs of these genes will provide insights into the role of these APP orthologs in early embryonic development.
3.
Functional studies in mouse models 3.1. Single, double, and triple knockouts of APP family genes Mice lacking every possible combination of APP family proteins have been generated (see Table 2 ; reviewed in Anliker and Mü ller, 2006; Zheng and Koo, 2006; Mü ller and Zheng, 2012) . Individual deletions of APP or APLPs produce extremely mild phenotypes; this is likely due to overlap in function between family members. APP-KO mice (two complete KOs and one hypomorphic mutation of APP) are viable and fertile. In addition to CNS abnormalities, they had reduced body weight (15-20% smaller) and a deficit in grip strength (Zheng et al., 1995; Ring et al., 2007) implying a defect in neuromuscular transmission or muscle contraction. The only abnormality of APLP1-KO mice was a somatic growth deficit; locomotor activity and grip strength were normal (Heber et al., 2000) . No abnormalities have been found for APLP2-KO mice (von Koch et al., 1997) , suggesting that APP and APLP1 can compensate for the loss of APLP2. However, APLP-deficient mice have not been examined in comparable detail as APP-KOs, and in light of more recent findings in the double KO and knockin (KI) mice, it would be worthwhile to reanalyze phenotypes of APLP KOs.
In contrast to the subtle phenotypes of single mutants, double knockout mice (DKO) carrying APLP2/APLP1 or APLP2/APP deficiencies died within the first day after birth (von Koch et al., 1997; Heber et al., 2000) . Surprisingly, APLP1/APP-deficient mice were viable and fertile; the only abnormality was a reduced body weight similar to that of APP-deficient mice (Heber et al., 2000) . These data confirm an essential physiological role for APLP2 and indicate partial redundancy between APLP2 and the other two family members. Neither of the lethal double mutants, however, displayed obvious histopathological abnormalities (examined at the light microscopic level) in the brain.
Although the lethality of the APP/APLP2-DKO shortly after birth precluded the analysis of APP/APLP2 mediated functions in the later postnatal and adult nervous system, Wang et al. (2005) studied diaphragm preparations from newborn APP/ APLP2-DKO mice. They found that APP and APLP2 play a redundant and essential role for neuromuscular synapse formation and function. There was excessive nerve growth, a widened endplate pattern, reduced apposition of pre-and postsynaptic components, and severely impaired spontaneous and evoked neurotransmission . Moreover, synapses of the submandibular ganglion, a cholinergic parasympathetic ganglion, were studied with transmission electron microscopy. These synapses in APP/APLP2-DKO mice showed a reduction in active zone size, synaptic vesicle density, and number of docked vesicles , all of which would produce presynaptic defects. Whether lethal APLP2/APLP1-DKO mice show similar NMJ abnormalities will await further studies. It is clear from the lethality of APLP1/ APLP2-DKO mice that by itself, APP expression is not sufficient for survival. Since expression of APLP2 alone (in the viable APP/APLP1 DKO mice) is sufficient for survival, it is worth considering the provocative possibility that APLP2 is more important than APP for normal physiological functions (at least at the NMJ). Thus, impaired function of the NMJ likely causes not only early postnatal lethality of combined mutants but also defects in grip strength in APP single KOs. Indeed, subsequent analysis of neuromuscular transmission of APP-KO mice showed reduced paired pulse facilitation that was associated with an increase in asynchronous presynaptic transmitter release mediated by N-and L-type Ca 2+ channels . Triple KO mice lacking all three APP family members die shortly after birth. Unlike the DKO mutants, which had no histological alterations in the brain, 80% of all triple knockouts showed cranial abnormalities (Herms et al., 2004) . Within affected areas, neuronal cells from the cortical plate migrated beyond their normal positions and protruded into the marginal zone and the subarachnoid space, indicating a critical role for APP family members in neuronal adhesion and/or positioning (Herms et al., 2004) . One possible explanation for the appearance of the neuronal ectopias in triple knockout mice would be an alteration in the basal membrane (BM), which underlies the pia mater that is in direct contact with the brain surface. Such BM defects could be due to either a failure in the proper assembly of the basal lamina or impairment in the attachment of glial endfeet to the basal lamina. Loss of APP/APLP interactions with extracellular matrix may also be one component responsible for defects observed at the neonatal NMJ (described below). Since about 20% of lethal triple mutants have no histological brain abnormalities and because mutants with similar focal ectopias survive beyond birth, it is likely that the cause of death of the triple KOs, like that of the lethal double KOs, is due to defective synaptic transmission at the neuromuscular junction. These data from double and triple KOs make it clear that the APP gene family has an essential role for normal PNS and CNS development.
3.2.
APPsa, but not APPsb, rescues the lethality of APP/ APLP2-DKO Distinct domains of APP are crucial for its function. There is extensive evidence that APPsa has neuroprotective activity. In cell lines and primary neurons APPsa was shown to promote neurite outgrowth and axonal branching and to modulate cell excitability. Moreover, there is substantial evidence for a neuroprotective function of APP and APPsa against apoptotic stimuli (reviewed in Kö gel et al., 2012). Remarkably, APPsa production itself is activity-dependent and can be upregulated by electrical stimulation and activation of neurotransmitter receptors including mGluRs, muscarinic AChR, and NMDA-R (reviewed in Fahrenholz, 2007) . Thus, APPsa production is suggested to function as a feedback mechanism by which neurons protect themselves from overexcitation, proteasomal stress, and traumatic brain injury (Taylor et al., 2008; Copanaki et al., 2010; Corrigan et al., 2011 Corrigan et al., , 2012 . The effects of APPsa contrast sharply with those of APPsb, which are usually described as deleterious (Li et al., 1997) , less neuroprotective (Furukawa et al., 1996) or having no effect (Copanaki et al., 2010) . Notably, even though APPsb alters gene expression of Klotho and transthyretin, it is unable to rescue the lethality of APP/APLP2 DKO mice (Li et al., 2010) . One cautionary comment about the comparisons of APPsa and APPsb is that it would be overly simplistic to equate APPsa with ''good effects'' and APPsb with ''bad effects.'' Like all tissues, the nervous system must enact a controlled sculpting during development and maturity. Neurodegeneration during development and the removal or weakening of synapses are as important as creating new neurons and forming new synapses for synaptic plasticity.
When APP and APLP2 are both absent, the majority of mice die shortly after birth; survival varies from 5-20%, depending on the genetic background (von Koch et al., 1997; Heber et al., 2000; Weyer, personal communication) . A line of mutant mice (APPsa-KI) was created by inserting a stop codon in the endogenous APP gene immediately after the a-secretase cleavage site (Ring et al., 2007; Fig. 1B ). These animals make only the secreted APPsa protein with no other proteolytic products of APP. The APPsa domain is capable of rescuing motor, behavioral, and LTP deficits observed in APP-KO mice (Ring et al., 2007) . This compensation is consistent with the ability of the secreted ectodomain to rescue APP homolog deletions in C. elegans (see above). Crossing these APPsa-KI mice to APLP2 À/À animals created a double mutant line that lacked APLP2 and expressed APPsa (designated APPsa-DM). The majority of APPsa-DM mice survive, making it possible to test the importance of different domains of APP for behavior and synaptic function of adult mice (Weyer et al., 2011) . APPsa-DM adult mice have impaired muscle function as measured by grip strength. Muscle weakness could arise from contraction defects and/or deficits in neuromuscular transmission. These mice had both pre-and postsynaptic structural aberrations with excessive branching of nerve terminals, fragmented postsynaptic receptor domains, and misalignment of pre-and postsynaptic membranes. Recording of neuromuscular transmission in young adult APPsa-DM mice revealed numerous presynaptic functional deficits; presynaptic terminals have fewer release sites and are impaired in their ability to recruit vesicles during maintained stimulation. These NMJ synaptic defects could be a consequence of APP not being tethered to the membrane and/or missing its C-terminal cytoplasmic domain. This question can be resolved using knockin mice with a deletion of only the intracellular domain. In retrospect, it should not be surprising that the APPsa-DM mice have defects involving synaptic vesicle release. There are multiple reports that APP is transported in vesicles by very fast anterograde axonal transport (reviewed by Brunholz et al., 2012) . These APP-containing vesicles transport some synaptic proteins (for example, synapsin-1, SNAP25, and VAMP2) but not others (e.g., piccolo, bassoon, and Munc-18). These vesicles also contain an asecretase (ADAM10), which is active during transport (Szodorai et al., 2009) , permitting the secretion of APPsa at the synaptic terminal during nerve activity (Farber et al., 1995) . Groemer et al. (2011) have shown that a small fraction of synaptic vesicles contain and release APP; this would be consistent with the evidence that the vast majority of vesicles, the reserve pool, does not directly take part in vesicle release but instead serves as a buffer for soluble synaptic proteins (Denker et al., 2011) . There are different pools of synaptic vesicles in the nerve terminal (Denker and Rizzoli, 2010) , and the relationship between the APP-transporting vesicles and these pools is not clear. However, it is intriguing to note that synapsin-1 is both co-transported with APP and is likely to contribute to the immobility of the reserve/mature pool. Mint/X11, a presynaptic scaffolding protein, binds both APP and Munc18 (Weyer et al., 2011) . Because Munc18 is absolutely required for exocytosis at active zones, we speculate that APP may participate in the transition between different pools of synaptic vesicles during synaptic transmission.
Conditional KOs
Germline deletion of APP and APLP2 in mice results in a major impairment in pre-and postsynaptic patterning and defective synaptic transmission at the NMJ, as well as a specific defect in presynaptic targeting of the high affinity choline transporter . Conditional alleles of APP and APLP2 have been generated Mallm et al., 2010) . Consistent with both the adhesion properties of APP (Soba et al., 2005) and presumed signaling roles, deletion of APP (on a global APLP2-KO background) in either presynaptic motor neurons (N-DKO) or in postsynaptic muscle (M-DKO) was shown to lead to neuromuscular synapse defects ) that were largely similar to those in the germline deletions. It is anticipated that there would be a strong correlation between strength of neuromuscular transmission and survival rate, but the fraction of animals that survive in the conditional DKOs was not reported. Surprisingly, the same authors reported in a later study that N-DKO mice, but not the M-DKO mice, are viable and overcome the postnatal lethality of global DKO mice (Li et al., 2010) . At the NMJ, the interplay between APP and APLPs that can form homo-or heterotypic cis-and trans-dimers (Soba et al., 2005) appears to be complex. Earlier genetic studies had indicated that homotypic transsynaptic adhesion at the NMJ mediated solely between pre-and postsynaptic APP is not sufficient for survival as APLP1/APLP2-DKO mice die shortly after birth (Heber et al., 2000) , despite expressing normal amounts of APP. Thus, a more detailed understanding of the specific function(s) of APP family members at peripheral and central synapses is needed.
Interestingly, postsynaptic APP expression is required to mediate presynaptic CHT targeting and synaptic transmission, suggesting that transsynaptic APP/APP interaction is necessary in recruiting the presynaptic APP/CHT complex and cholinergic synaptic function . APP may modulate other synaptic processes through signaling and/or binding to other synaptic proteins.
Conclusions from in vivo studies
Experiments in both flies and mice have revealed the importance of APP/APLPs in the structure and function of presynaptic and postsynaptic specializations at the NMJ. It is likely that these deficits are the immediate underlying cause of lethality shortly after birth in the double and triple KO mice. Interpretation of the lethality in C. elegans is more difficult since synaptic transmission was studied indirectly by applying compounds to the entire animal. At first glance, it is remarkable that many more alterations were observed in presynaptic versus postsynaptic properties. This may be true as well for the CNS since studies of organotypic slices and neurons from APP/APLP2 DKO mice reported that glutamatergic synaptic transmission as well as release and reuptake of glutamate was decreased (Schrenk-Siemens et al., 2008) . This could indicate a more important role of APP/APLP in presynaptic function or be a consequence of reduced attention paid to postsynaptic properties. Regardless of the site of action of APP/APLPs, bidirectional signaling across the synapse implies that we can always expect to find both pre-and postsynaptic alterations.
Presynaptic effects
(1) Change in miniature endplate potential (mepp) frequency with either a large decrease (DKO, APP
), both of which imply either a change in the number of active zones or an inability to regulate the basal level of calcium in the terminal. (2) Reduced quantal content, which reflects the combined effects on probability of release and the number of active zones. (3) Reduced readily releasable pool of vesicles implies fewer active zones in APPsa-DM mice. (4) Reduced size of active zones (measured by electron microscopy) in the submandibular ganglion. (5) Inability to maintain a high rate of release during a train of action potentials implies that the recruitment of secondary vesicles to the docking sites is impaired. (6) Deficit in calcium channel localization implies that APP participates in the structural organization of presynaptic release sites. (7) Deficit in targeting of the choline transporter to the nerve terminal is further evidence that APP is needed for localization of presynaptic proteins. (8) Short term plasticity, as defined by paired pulse facilitation, was affected in some models and not in others. It is possible that some of these defects are ultimately due to impaired processing in the secretory pathway and reduced axonal transport of vesicles to the presynaptic terminal.
4.2.
Postsynaptic effects
(1) Increased width of the endplate band indicates an altered recognition between the growing axon and the muscle fiber. (2) Adult APPsa-DM mice have three types of endplate AChR distributions: a normal, pretzel-like shape; an apparent fragmentation into multiple, discreet islands of receptors; and a diffuse, immature shape. The fragmented topology has been observed under a wide variety of conditions (e.g., BDNF receptor changes, and collagen and laminin KOs). Unfortunately, the molecular basis of the normal, pretzel-like topography is poorly understood.
Cellular and molecular interactions of APP/ APLPs
The presynaptic axon terminal and the postsynaptic muscle cell are typically the focus of attention at the NMJ. However, two other cell types contribute to the neuromuscular complex: terminal Schwann cells and a newly described fibroblast-like cell termed the kranocyte (Court et al., 2008) that caps the terminal Schwann cell and extends over the perisynaptic muscle membrane ( Fig. 2A) . All four of these cells are likely to participate in the functions of APP/APLPs at the NMJ. These cell types can interact with each other in each of six possible cell-cell combinations. Neuregulin provides an example illustrating the importance of identifying specific cell-cell interactions at the NMJ. It was originally thought that neuregulin is expressed by motor neurons and acts on muscle ErbB receptors. However, mice lacking ErbB receptors still form synapses (Escher et al., 2005) ; this puzzling result was resolved by discovering that neuregulin acts as a Schwann cell survival and growth factor, which indirectly promotes synapse formation and controls axon myelination (Newbern and Birchmeier, 2010) . Interestingly, neuregulin is a major substrate of the same b-secretase (BACE-1) that cleaves APP; this creates neuregulin proteolytic fragments similar to those described for APP (Fleck et al., 2012) . Since APP/APLPs can act as ligands and receptors, it is essential to determine the isoforms expressed by each cell type. APP and APLP2 are probably expressed in all four cell types since they are assumed to be expressed in most or all tissues and cells. In contrast, APLP1 is reported to be restricted to neurons in the CNS and is absent in P0 muscle and fibroblasts (Wasco et al., 1992; Lorent et al., 1995; Herms et al., 2004; Wang et al., 2009; Guo et al., 2012) . Functions served by the APP family in each of these cells can be studied using conditional knockout mice, as has been done for APP expression in the motoneuron and muscle fiber.
5.1.
Potential binding partners for APP/APLPs at the NMJ Double and triple KOs in the mouse show that APP/APLPs must be critical for creating synapses sufficiently powerful for survival. Nevertheless, the initial stages of synapse formation do not require APP/APLPs because triple KO mice survive many hours after birth, and Bergmans et al. (2010) showed that pyramidal CNS neurons derived from triple-KO embryonic stem (ES) cells by in vitro differentiation form functional synapses. What are the molecular mechanisms of APP/APLP action? APP interacts with multiple proteins important for synapse formation (Fig. 2B ) with additional synaptic interacting proteins undoubtedly remaining to be identified. The location and developmental expression of these protein interactions will provide a starting point for the difficult task of determining their roles in synapse formation and plasticity. The assumption is that the loss of these interactions could contribute to cognitive decline seen in AD. What APP/APLP binding proteins or protein complexes are found in (1) the postsynaptic cell, (2) the synaptic cleft, and (3) the presynaptic terminal, and what proteins are good candidates to be novel binding partners of APP/APLP?
Postsynaptic muscle cell
Although the accepted scheme of synaptogenesis at the NMJ has altered in the last few years (Kummer et al., 2006) , the importance of proteins already identified remains well established. Agrin, Lrp4, and MuSK form an essential postsynaptic complex and Lrp4 is also critical for presynaptic development (Wu et al., 2012; Yumoto et al., 2012) . Previous studies identified agrin as a component of Ab plaques, showed that agrin binds Ab fibrils but not soluble Ab, and found that agrin accelerated Ab fibril formation (Cotman et al., 2000) . It remains to be seen whether agrin may also bind to the Ab region embedded in full length APP. APP binds members of the lipoprotein receptor family (see review by Wagner and Pietrzik, 2012) and may bind Lrp4 and/or MuSK. Other molecules known to be critical for postsynaptic NMJ formation and maintenance are rapsyn, which crosslinks AChRs in the postsynaptic membrane (Burden et al., 1983) , and asyntrophin, which is important for AChR stability (MartinezPena y Valenzuela et al., 2011) . Additional molecules worth testing are those involved in the Wnt and b-catenin signaling pathways (Wu et al., 2010; Korkut and Budnik, 2009 ).
Intercellular matrix
The synaptic cleft is replete with secreted proteins that link cells in the synaptic region, such as components of the extracellular matrix (ECM) and basal lamina (BL, e.g., laminins, heparan sulfate proteoglycans, and collagens). The synaptic ECM/BL, recently designated the synaptomatrix, was shown by McMahan and colleagues to be a key component of synapse formation and regeneration (reviewed by McMahan and Wallace, 1989 and more recently by Dani and Broadie, 2012) . APP has been shown to bind ECM molecules such as collagen, heparin, and laminin (Kibbey et al., 1993; Beher et al., 1996; Clarris et al., 1997) , including synapse-specific collagen IV (Narindrasorasak et al., 1995; Beher et al., 1996) . There is evidence that specific laminins, collagens, and fibroblast growth factors (FGFs) secreted by the muscle assist in orchestrating the development, maturation, and maintenance of the neuromuscular junction (Fox et al., 2007; Patton et al., 1997; Latvanlehto et al., 2010 ; for review, see Singhal and Martin, 2011) . Although APP binds heparan sulfate proteoglycans (HSPG), binding of APP to agrin (an HSPG) remains to be established (described above). Heparin binding has been localized to two regions of the APP ectodomain (see Clarris et al., 1997; Dahms et al., 2010) and a potential heparin binding site has been identified from a crystal structure of the APP extracellular domain (Rossjohn et al., 1999) . It is tempting to speculate that each of the four cell types at the synapse secretes a unique set of ECM molecules, creating a set of interconnected, heterogeneous ECM domains ( Fig. 2A) . This would create a quilt work of molecular partners for interactions with secreted/soluble or membrane-bound APP/APLPs.
Presynaptic terminal
This category includes proteins localized to the axon terminal as well as proteins that act as ligands for receptors at the presynaptic membrane. Since APP/APLPs are transmembrane proteins, they are capable of binding cytoplasmic, membrane, and extracellular molecules. Some molecular interactions have been identified at the biochemical level (albeit in the brain rather than the NMJ); two examples in the axon terminal are the plasma membrane choline transporter and L-type Ca channel Yang et al., 2009) . Synaptic Ca channels are primarily P/Q isoforms. L-type Ca channels are not typically associated with synaptic transmission, but L-type channels have been reported in developing and regenerating NMJ terminals in the frog and rodent (Sugiura and Ko, 1997) . Calcium channels may be important for structural organization of the active zone by a mechanism separate from its function of producing calcium influx (Nishimune et al., 2004; Nishimune, 2011 Nishimune, , 2012 . APP interacts with Mint/X11, providing a molecular link to Munc18 (Ashley et al., 2005; Weyer et al., 2011) . In addition, a ternary complex of APP with Mint1/X11 and the presynaptic organizer Cask has been identified in cultured hippocampal neurons . Proteins involved in determining the size or maintenance of active zones are abnormal in APP/APLP transgenic mice . A recent study to define the interactome of APP in the brain found many proteins associated with synaptic vesicle endo-and exocytosis; a direct interaction with synaptotagmin 1 was identified (Kohli et al., 2012) . DR6-KO mice have neuromuscular junction deficits similar to those of APP/APLP2-KO mice with long axons that overshoot the endplates (Nikolaev et al., 2009) . Although in principle, one may envisage that lack of APP/APLP binding and thus lack of DR6 signaling might cause these defects, it is noteworthy that APP/APLP1 double KOs and both APP and APLP2 single KOs do not show these abnormal NMJs. Proteins secreted by the postsynaptic targets or synapse-associated glial or fibroblast cells are excellent candidates for binding to APP/APLPs. These include signal regulatory proteins (SIRPs, Umemori and Sanes, 2008; Umemori et al., 2004) and members of the fibroblast growth factor family (FGF 7/10/22; Fox et al., 2007) .
Summary
In vivo experiments in flies, worms, zebrafish, and mice definitively establish that the APP/APLP family is crucial for synapse development and maintenance at the NMJ. The molecular mechanisms that link APP/APLP to synaptic morphology and function remain to be determined. Some protein interactions have been identified, but it is likely that many more exist. Basic questions remain. Which APP/APLP family members and which splicing isoforms are expressed by the four cell types at the synapse? Is processing by secretases different for each of the cell types at the NMJ? Do APP/APLPs bind multiple proteins known to be critical for synapse formation and clustering of acetylcholine receptors? In addition to Mint/X11, synaptotagmin 1, and calcium channels, what other components of the active zone bind APP/APLP? Are both the adhesive properties and signaling functions of APP/APLP essential for its participation in the maturation and maintenance of the NMJ? Identification of the cells and proteins that interact with APP/APLP will establish focal points for molecular dissection of APP's functional roles. These may lead to insights into similar roles at CNS synapses and suggest potential contributions to cognitive deficits that underlie AD.
